Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Assets
Cash and cash equivalents	$ 79,314	$ 42,273
Restricted cash	117	269
Contracts and accounts receivable	15,982	18,265
Due from affiliates	238	1,218
Real estate inventories	433,938	566,290
Investment in and advances to unconsolidated joint ventures	30,217	34,330
Other assets	43,383	33,452
Total assets	603,189	696,097
Liabilities and equity
Accounts payable	25,044	39,391
Accrued expenses and other liabilities	40,554	29,028
Unsecured revolving credit facility	0	67,500
Senior notes, net	304,832	320,148
Total liabilities	370,430	456,067
Commitments and contingencies (Note 11)
Stockholders' equity:
Preferred stock, $0.01 par value, 50,000,000 shares authorized, no shares outstanding	0	0
Common stock, $0.01 par value, 500,000,000 shares authorized, 20,096,969 and 20,058,904, shares issued and outstanding as of December 31, 2019 and December 31, 2018, respectively	201	201
Additional paid-in capital	193,862	193,132
Retained earnings	38,584	46,621
Total stockholders' equity	232,647	239,954
Non-controlling interest in subsidiary	112	76
Total equity	232,759	240,030
Total liabilities and equity	$ 603,189	$ 696,097